| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.0046 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.00098 | 1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00094 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.00043 | 1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.00045 | 1 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.00031 | 1 |